UNSPSC 51184004: Glibenclamide or glyburide

This classification denotes a cation channel blocker and anti-diabetic agent with the molecular formula C23H28ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SX6K58TVWC, chemically known as urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl- but more generally known as glibenclamide, which bears US NIH Compound Identifier 3488.

UNSPSC 51184004 Glibenclamide or glyburide is a Commodity code for a specific oral diabetes medication. State and local governments procure this drug primarily through institutional pharmacy programs and bulk purchasing vehicles serving public health departments, correctional facilities, Veterans Affairs clinics, and safety-net hospital systems. The medication is a second-generation sulfonylurea used to manage Type 2 diabetes and is typically acquired as a generic pharmaceutical in tablet form through state pharmaceutical contracts or cooperative purchasing agreements such as those managed by the National Intergovernmental Purchasing Alliance (NJPIES) or state-specific group purchasing organizations. Solicitations under this code are issued by state health departments, county health systems, municipal hospitals, and prison health services.

The source material contains no recent state and local contract opportunities tagged to UNSPSC 51184004 Glibenclamide or glyburide.